Seeing Is Believing
with an average price target of $16.95. This is a potential upside of $4.45 (35.6%) from yesterday's end of day stock price of $12.5.
POINT Biopharma Global's activity chart (see below) currently has 29 price targets and 22 ratings on display.
Analysts average stock forecasts to be materialized ratio is 35% with an average time for these price targets to be met of 75.5 days.
Most recent stock forecast was given by KEMP DOLLIVER from BROOKLINE on 20-Dec-2023.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$12.5
$27
1 years 10 months 8 days ago
(20-Dec-2023)
1/3 (33.33%)
$0.03 (0.24%)
5
Hold
$12.5
$17
2 years 5 days ago
(23-Oct-2023)
1/3 (33.33%)
$-0.16 (-1.26%)
55
Hold
$13
2 years 23 days ago
(05-Oct-2023)
2/2 (100%)
$3.73 (40.24%)
156
Hold
$22
2 years 24 days ago
(04-Oct-2023)
0/1 (0%)
$13.49 (158.52%)
Hold
$12.5
$14
2 years 25 days ago
(03-Oct-2023)
2/3 (66.67%)
$0.1 (0.81%)
199
What is PNT (POINT Biopharma Global) average time for price targets to be met?
Which analyst has the current highest performing score on PNT (POINT Biopharma Global) with a proven track record?
Which analyst has the most public recommendations on PNT (POINT Biopharma Global)?
Which analyst is the currently most bullish on PNT (POINT Biopharma Global)?
Which analyst is the currently most reserved on PNT (POINT Biopharma Global)?